Pernix Therapeutics Inc. to Present at Morgan Stanley Global Healthcare Conference
09 sept. 2015 07h00 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Sept. 9, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and...
Pernix Therapeutics Announces New Revolving Credit Facility
24 août 2015 10h46 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Aug. 24, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or "the Company"), a specialty pharmaceutical company, today announced the completion of a...
Pernix Therapeutics Reports Second Quarter 2015 Financial Results
06 août 2015 06h50 HE
|
Pernix Therapeutics Holdings, Inc.
Revenues Increase Over 150% Year-Over-Year
Company Provides Updated Financial Guidance
MORRISTOWN, N.J., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX)...
Pernix Releases Positive in vitro Abuse Deterrent Data for Third Generation Extended Release Hydrocodone ZX007
27 juil. 2015 08h00 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., July 27, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced positive results from Category 1 (in...
Pernix Therapeutics Inc. to Report Second Quarter 2015 Financial Results on Thursday, August 6, 2015
24 juil. 2015 11h30 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., July 24, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release its 2015 second quarter...
Pernix Therapeutics Inc. to Present at JMP Securities Life Sciences Conference
15 juin 2015 17h30 HE
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., June 15, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (Nasdaq:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and...